Fibrate therapy in primary sclerosing cholangitis: missing data on lipids, interactions, and cancer risk

Digestive and Liver Disease · Published 2026-06-01 · DOI 10.1016/j.dld.2026.06.006

Free full text

Authors (2)

Yanzuo Wu, Ze Yang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wu, Y., Yang, Z. (2026). Fibrate therapy in primary sclerosing cholangitis: missing data on lipids, interactions, and cancer risk. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.06.006

Related articles

• Author’s reply: “Fibrate therapy in primary sclerosing cholangitis" · Digestive and Liver Disease · 2026 · Cites or is cited by this article · Same journal
• Laparoscopy-assisted mesenteric vein access for portal vein recanalization and Transjugular intrahepatic portosystemic shunt: A novel TIPS approach for cavernous transformation of the portal vein · Digestive and Liver Disease · 2026 · Same journal
• The “starry sky” sign of intrahepatic biliary hamartoma · Digestive and Liver Disease · 2026 · Same journal
• Double immunohistochemistry to detect transglutaminase 2-IgA deposits in celiac children: a multicentre study · Digestive and Liver Disease · 2026 · Same journal
• A Solitary solid-appearing multicystic bile duct hamartoma mimicking hepatocellular carcinoma · Digestive and Liver Disease · 2026 · Same journal
• Pharmacovigilance of drug-induced microscopic colitis: time to consider exposure duration and dechallenge completeness · Digestive and Liver Disease · 2026 · Same journal
• Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression · Digestive and Liver Disease · 2026 · Same journal
• Hepatic portal venous gas: An ominous sign of death · Digestive and Liver Disease · 2026 · Same journal
• A multimodal artificial intelligence method for accurate diagnosis of autoimmune gastritis · Digestive and Liver Disease · 2026 · Same journal
• Pattern-based histologic approach in colitis without chronic architectural damage: GIPAD recommendations · Digestive and Liver Disease · 2026 · Same journal